Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis

Function and Activation of NF-kappaB in the Immune System

1994 • 4,698 citations

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

2002 • 4,011 citations

NF-κB regulation in the immune system

2002 • 3,804 citations

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin

2000 • 3,789 citations

HMG-1 as a Late Mediator of Endotoxin Lethality in Mice

1999 • 3,314 citations

A protein kinase involved in the regulation of inflammatory cytokine biosynthesis

1994 • 3,285 citations

The inflammatory reflex

2002 • 3,274 citations

Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation

2002 • 2,972 citations

Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia

1987 • 2,492 citations

Independent Human MAP-Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms

1995 • 1,562 citations

High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes

2000 • 1,385 citations

Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion

2003 • 1,200 citations

Reversing established sepsis with antagonists of endogenous high-mobility group box 1

2003 • 1,105 citations

Acetylcholine receptor channel imaged in the open state

1995 • 1,002 citations

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1994 • 920 citations

Emerging structure of the Nicotinic Acetylcholine receptors

2002 • 896 citations

Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway

1999 • 800 citations

The interleukin‐1 family: 10 years of discovery ¹

1994 • 784 citations

Novel strategies for the treatment of sepsis

2003 • 784 citations

Protection from septic shock by neutralization of macrophage migration inhibitory factor

2000 • 728 citations

Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome

1994 • 714 citations

Epidemiology of Sepsis Syndrome in 8 Academic Medical Centers

1997 • 662 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

1998 • 618 citations

Has the mortality of septic shock changed with time?

1998 • 616 citations

Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation

2002 • 589 citations

Pharmacological Stimulation of the Cholinergic Antiinflammatory Pathway

2002 • 507 citations

Nicotinic acetylcholine receptors: from structure to brain function

2003 • 487 citations

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

1998 • 458 citations

Inflammation, coagulopathy, and the pathogenesis of multiple organ dysfunction syndrome

2001 • 446 citations

Muscarinic Acetylcholine Receptor Knockout Mice: Novel Phenotypes and Clinical Implications

2004 • 371 citations

Structural Basis for the Proinflammatory Cytokine Activity of High Mobility Group Box 1

2003 • 343 citations

Quality-adjusted Survival in the First Year after the Acute Respiratory Distress Syndrome

2001 • 334 citations

Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

1992 • 326 citations

IFN-γ Induces High Mobility Group Box 1 Protein Release Partly Through a TNF-Dependent Mechanism

2003 • 317 citations

Therapeutic effects of lysophosphatidylcholine in experimental sepsis

2004 • 309 citations

Efferent Vagal Fibre Stimulation Blunts Nuclear Factor-κB Activation and Protects Against Hypovolemic Hemorrhagic Shock

2003 • 306 citations

Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: A randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients

2001 • 289 citations

Epidemiology of sepsis syndrome in 8 academic medical centers. Academic Medical Center Consortium Sepsis Project Working Group

1997 • 260 citations

Cigarette Smoking and Ulcerative Colitis

1983 • 188 citations

Therapeutic strategies to reduce IL-1 activity in treating local and systemic inflammation

2004 • 187 citations

HMGB1 is a potent trigger of arthritis

2004 • 164 citations

Depletion of casein kinase II by antisense oligonucleotide prevents neuritogenesis in neuroblastoma cells.

1993 • 160 citations

High mobility group box chromosomal protein 1 as a nuclear protein, cytokine, and potential therapeutic target in arthritis

2003 • 89 citations

At the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1

2002 • 72 citations

HMGB1 in the Immunology of Sepsis (Not Septic Shock) and Arthritis

2004 • 52 citations

MIF mediation of sepsis

2000 • 25 citations